BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• RedHill Biopharma Prices Public Offering of its American Depositary Shares

  Gross proceeds from the sale of the ADSs by RedHill before underwriting discounts and commissions and other offering expenses are expected to be approximately $22.5 million.

  November 8, 2017

   · 

  7 min read
• Business

  Aquinox Pharmaceuticals Announces Third Quarter 2017 Financial Results

  Cash, cash equivalents, short-term and long-term investments totaled $119.7 million as of September 30, 2017, compared to $153.1 million as of December 31, 2016.

  November 8, 2017

   · 

  8 min read
• New Patents Granted for Khondrion’s Mitochondrial Disease Lead Compound KH176

  Khondrion announces today the grant of key patents in the United States of America, Europe and Hong Kong.

  November 8, 2017

   · 

  2 min read
• 

  Hedge Fund Takes Another Shot at Biotech, This Time at Prothena

  Kerrisdale believes that Prothena’s lead drug NEOD001 will fail in its current Phase 2b and Phase 3 trials.

  November 8, 2017

   · 

  1 min read
• Drug Development

  Zosano Pharma Announces Initiation of Long-Term Safety Study for M207 as an Acute Treatment of Migraine

  M207-ADAM is an open label study evaluating the safety of the 3.8mg dose of zolmitriptan in migraine patients who have historically experienced at least 2 migraines per month.

  November 8, 2017

   · 

  5 min read
• Business

  Jounce Therapeutics to Announce Third Quarter 2017 Financial Results and Host Conference Call on Monday, November 13, 2017

  Management will host a conference call and live audio webcast to discuss these results and provide a corporate update at 8:00 a.m. ET.

  November 8, 2017

   · 

  1 min read
• Deals

  Mesa Labs Acquires Sterilization and Disinfection Process Control Business

  Mesa purchased only the Hygiene Monitoring business from BAG and as a result, the sale and service of their other business divisions will continue as normal and are not affected in any way by the acquisition of the Hygiene Monitoring business.

  November 8, 2017

   · 

  4 min read
• Business

  Cambrex Invests in New Small Scale Capacity at Its Charles City, Iowa Facility

  The project has seen the installation of two 500 gallon glass lined reactors and creates a third small scale work center, further increasing flexibility for customer projects.

  November 8, 2017

   · 

  2 min read
• Business

  Skyline Medical Announces Two Proposed Joint Ventures and New Strategic Focus on CRO Services

  New collaborations with Helomics and CytoBioscience to diversify Skyline’s operations into the rapidly growing CRO Services sector.

  November 8, 2017

   · 

  8 min read
• Business

  SYGNIS AG Reports Financial Results for the Third Quarter and First Nine Months of 2017

  Revenues increased 4-fold to € 5.3M for the first nine months of 2017 through a combination of organic and acquisitive growth.

  November 8, 2017

   · 

  8 min read